← All stocks

Arcus Biosciences, Inc.

RCUS No buying or selling

CIK 0001724521 #1577 in the set updated 21 Sep 2026

Bought (1 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (1 mo)

$0.00

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$0.00

0 of 0 sales

Net

$0.00

$0.00 against sales at will

By person

16 insiders · 0 transactions

Insider

Role

Bought

Sold

Net

Holding

Worth

Change

GILEAD SCIENCES, INC. entity

10% owner

—

31,424,760

$942.74M

+4.5%

ROSEN TERRY J

Chief Executive Officer

—

2,236,409

$67.09M

+6.4%

Jaen Juan C.

President

—

1,199,252

$35.98M

−21.2%

Jarrett Jennifer

Chief Operating Officer

—

224,024

$6.72M

+16.8%

Tang Carolyn C.

General Counsel

—

184,607

$5.54M

+60.1%

Markus Richard

Chief Medical Officer

—

89,647

$2.69M

—

Nuyten Dimitry SA

Chief Medical Officer

—

87,518

$2.63M

−8.2%

Goeltz II Robert C.

Chief Financial Officer

—

84,161

$2.52M

+14.0%

Lacey David L.

Director

—

76,652

$2.30M

+33.0%

PERLMAN ANDREW J

Director

—

48,325

$1.45M

+64.8%

FALBERG KATHRYN E

Director

—

44,300

$1.33M

+75.1%

Machado Patrick

Director

—

44,300

$1.33M

+75.1%

Ribas Antoni

Director

—

44,300

$1.33M

+46.0%

Lambert Nicole

Director

—

43,000

$1.29M

+79.2%

Azoy Alexander

Chief Accounting Officer

—

39,581

$1.19M

+69.1%

KANEKO YASUNORI

Director

—

25,700

$771.00K

—

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 1

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 0

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 0

History held since 19 Mar 2018